Place of death and chemotherapy use at the end of life in colorectal cancer.

被引：0
|
作者：
Schuette, Katharina
Kroggel, Tobias
Rentsch, Anke
Schuler, Ulrich S.
Heuchel, Conrad
Folprecht, Gunnar
机构：
[1] Univ Hosp Carl Gustav Carus, Dresden, Germany
[2] Univ Hosp Dresden, Dresden, Germany
[3] Tech Univ Dresden, Univ Canc Ctr, Univ Hosp Carl Gustav Carus, Dresden, Germany
[4] Tech Univ Dresden, Univ Klinikum, Palliat Ctr, Dresden, Germany
[5] Tech Univ Dresden, Univ Klinikum, Med Klin 1, Dresden, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
10.1200/JCO.2019.37.15_suppl.e23006
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e23006
引用
收藏
页数：1
相关论文
共 50 条
  • [41] A change in the host immunity in patients treated by chemotherapy for colorectal cancer.
    Yoshimatsu, Kazuhiko
    Kobayashi, Rie
    Ishibashi, Keiichiro
    Yokomizo, Hajime
    Ogawa, Kenji
    [J]. CANCER RESEARCH, 2006, 66 (08)
  • [42] Temporal trends in receipt of adjuvant chemotherapy for veterans with colorectal cancer.
    Martin, Richard Lewis
    Edwards, Gretchen C.
    Samuels, Lauren R.
    Eng, Cathy
    Roumie, Christianne L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [43] Comparative effectiveness of chemotherapy in elderly patients with metastatic colorectal cancer.
    Satram-Hoang, Sacha
    Ramanan, Devi
    Lee, Luen F.
    Yu, Shui
    Reyes, Carolina M.
    McKenna, Edward
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [44] The effect of gaps in chemotherapy in patients with stage IV colorectal cancer.
    Sada, Yvonne
    Davila, Jessica
    El-Serag, Hashem
    Duan, Zhigang
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [45] The utilization of chemotherapy and radiation at the end of life in individuals with metastatic non-small cell lung cancer.
    Stavas, Mark J.
    Martin, Sara F.
    Phillips, Sharon E.
    Perkins, Stephanie Mabry
    Shinohara, Eric T.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (29)
  • [46] The impact of chemotherapy delays on quality of life in patients with cancer.
    Calhoun, EA
    Chang, CH
    Welshman, EE
    Cella, D
    [J]. BLOOD, 2003, 102 (11) : 749A - 749A
  • [47] Chemotherapy Use, Performance Status, and Quality of Life at the End of Life
    Prigerson, Holly G.
    Bao, Yuhua
    Shah, Manish A.
    Paulk, M. Elizabeth
    LeBlanc, Thomas W.
    Schneider, Bryan J.
    Garrido, Melissa M.
    Reid, M. Carrington
    Berlin, David A.
    Adelson, Kerin B.
    Neugut, Alfred I.
    Maciejewski, Paul K.
    [J]. JAMA ONCOLOGY, 2015, 1 (06) : 778 - 784
  • [48] Chemotherapy and palliative care near end-of life: examining the appropriateness at a cancer institute for colorectal cancer patients
    Ilaria Massa
    Oriana Nanni
    Flavia Foca
    Marco Maltoni
    Stefania Derni
    Nicola Gentili
    Giovanni Luca Frassineti
    Andrea Casadei Gardini
    Martina Valgiusti
    Dino Amadori
    Elena Prati
    Mattia Altini
    Davide Gallegati
    Elisabetta Sansoni
    [J]. BMC Palliative Care, 17
  • [49] Chemotherapy and palliative care near end-of life: examining the appropriateness at a cancer institute for colorectal cancer patients
    Massa, Ilaria
    Nanni, Oriana
    Foca, Flavia
    Maltoni, Marco
    Derni, Stefania
    Gentili, Nicola
    Frassineti, Giovanni Luca
    Gardini, Andrea Casadei
    Valgiusti, Martina
    Amadori, Dino
    Prati, Elena
    Altini, Mattia
    Gallegati, Davide
    Sansoni, Elisabetta
    [J]. BMC PALLIATIVE CARE, 2018, 17
  • [50] Use of VEGF expression to predict for first-line treatment chemotherapy regimen in metastatic colorectal cancer.
    Ozkan, Metin
    Berk, Veli
    Deniz, Kemal
    Karaca, Halit
    Inanc, Mevlude
    Bozkurt, Oktay
    Duran, Ayse Ocak
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
12345